Directorate Change

AstraZeneca PLC
14 November 2002







ASTRAZENECA PLC - DIRECTORATE ANNOUNCEMENT





AstraZeneca PLC today announced that Ake Stavling will be leaving the Company on
31 January 2003.  Ake Stavling is 58 and has been an Executive Director since
April 1999.  He played a key role in the integration of Astra and Zeneca
following the merger in 1999 and since then has been responsible for Business
Development.  From 1993-1999 he was Executive Vice President and Chief Financial
Officer of Astra AB and before that held senior positions at Atlas Copco and
Ericsson.





G H R Musker

Company Secretary

14 November 2002


                      This information is provided by RNS
            The company news service from the London Stock Exchange                 SEFF